Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss
Akihito Nakanishi, Noriko Nagase, Hirokazu Kousaki, Bakushi Ogawa, Kazuhiro Horii, Iori Niitsu Morimoto, Yuka Morita, Fumiaki Nin · 2026
Read Bone-conducted ultrasonic auditory brainstem response thresholds in a mouse model of cisplatin-induced hearing loss by Akihito Nakanishi, Noriko Nagase, Hirokazu Kousaki, Bakushi Ogawa, Kazuhiro Horii, Iori Niitsu Morimoto, Yuka Morita, Fumiaki Nin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0353954.txt.
Description
Akihito Nakanishi and eight colleagues test a new way to probe hearing damage. The damage comes from a chemotherapy drug. Their mouse study appeared in PLOS ONE in 2026. The drug, cisplatin, saves lives. But it often costs patients their high-frequency hearing. The team delivered ultrasound through the skull bone. They measured the brain's electrical response. Then they compared shifts in two ranges. One was the bone-conducted ultrasound range. The other was the ordinary hearing range.
Ordinary thresholds worsened clearly after the drug. The ultrasound responses shifted much less. That mismatch carries a warning. The ultrasound route taps a different part of the hearing machinery. It cannot simply stand in for standard tests. Anyone hoping to use it as a quick damage gauge should take note.
Catalog record
| CREATOR | Akihito Nakanishi, Noriko Nagase, Hirokazu Kousaki, Bakushi Ogawa, Kazuhiro Horii, Iori Niitsu Morimoto, Yuka Morita, Fumiaki Nin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20039 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |